Fibrinolysis in ulcer disease
Malesević, M.; Pasić, R.; Pasić, I.; Curcic, B.; Andelić, M.
Medicinski Pregled 28(7-8): 301-305
1975
ISSN/ISBN: 0025-8105 PMID: 1160841 Document Number: 95471
Document emailed within 1 workday
Related Documents
Munkvad, S. 1993: Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways Danish Medical Bulletin 40(4): 383-408Kuznik, B.I.; Kulikova, S.V. 1982: Effect of histamine on blood coagulation and fibrinolysis in duodenal ulcer Terapevticheskii Arkhiv 54(2): 35-38
Chearanai, O.; Kachintorn, U.; Plengvanit, U. 1987: Efficacy of tripotassium-dicitrato-bismuthate (TDB) and cimetidine in peptic ulcer disease, a control study of 40 gastric ulcer and 80 duodenal ulcer Journal of the Medical Association of Thailand 70(4): 176-180
Belousov, A.S.; Papikian, G.A.; Lagutina, N.I.; Leont'eva, G.V.; Tumanian, M.A. 1981: Tissue fibrinolysis in the mechanism of gastroduodenal hemorrhage in patients with peptic ulcer Klinicheskaia Meditsina 59(2): 23-28
Kempf, Z. 1981: Evaluation of the coagulation and fibrinolysis systems in gastric and duodenal peptic ulcer patients Folia Medica Cracoviensia 23(2): 257-267
Ruzyłło, E.; Godziemba-Maliszewska, E.; Tacikowski, T. 1990: Natural history of peptic ulcer disease in Poland. Part VIII. Peptic ulcer disease and diseases of the liver, bile ducts and gallbladder Materia Medica Polona. Polish Journal of Medicine and Pharmacy 22(3): 225-232
Jovan P. Antovic 2003: Thrombin Activatable Fibrinolysis Inhibitor (TAFI) A Link between Coagulationand Fibrinolysis Clinical Laboratory 49(9-10): 475-486
Mignon, M. 1990: Prevention of ulcer recurrence and complications in duodenal ulcer disease. Maintenance treatment Gastroenterologie Clinique et Biologique 14(2 ): T1-T7
Chervinets, V.M.; Bazlov, S.N.; Chernin, V.V.; Strelets, E.V. 2002: Microflora of the peri-ulcer zone in patients with ulcer disease and its sensitivity to antibacterial agents Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 37-39; 191
Blum, A.L.; Peter, P.; Krejs, G.J. 1975: Pathogenesis and aetiology of ulcer disease. Part II: Duodenal ulcer Acta Hepato-Gastroenterologica 22(2): 123-128
Chung, S.Jin.; Lee, D.Ho.; Kim, N.; Jung, S.Hyang.; Kim, J.Wook.; Hwang, J.Hyeok.; Park, Y.Soo.; Lee, K.Hyuk.; Jung, H.Chae.; Song, I.Sung. 2007: Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease Hepato-Gastroenterology 54(76): 1293-1296
Anomasiri, W.; Thongthawee, B. 2005: Effects of cardiac rehabilitation on fibrinolysis in patients with coronary artery disease Journal of the Medical Association of Thailand 88(Suppl 4): S242-S248
Adány, R.; Szegedi, A.; Ablin, R.J.; Muszbek, L. 1988: Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease Thrombosis and Haemostasis 60(2): 293-297
Shchigel'skiĭ, V.I.; Shchurovkiĭ, I.V.; Brizinskiĭ, M.A.; Terno, V.S. 1978: Blood coagulation and fibrinolysis in patients with ischemic heart disease and arterial hypertension or hypotension Vrachebnoe Delo 5: 40-43
Andreenko, G.V.; Panchenko, V.M.; Lisina, A.N.; Liutova, L.V. 1978: Characteristics of the indicators of the blood coagulation and fibrinolysis systems in the pre-clinical stage of ischemic heart disease Kardiologiia 18(10): 57-60
Seliverstova, G.P.; Oranskiĭ, I.E. 1978: Rhythm of the daily fluctuations in lipid metabolic and fibrinolysis system indices in ischemic heart disease Kardiologiia 18(2): 130-132
Weiler, H.; Weiler, C.; Gerok, W. 1990: Gastric mucosal prostaglandin E2 levels in gastric non-ulcer and ulcer patients with chronic renal failure or without renal disease, and in healthy subjects Netherlands Journal of Medicine 37(5-6): 189-196
Tso, S.C.; Wong, V.; Chan, V.; Chan, T.K.; Ma, H.K.; Todd, D. 1980: Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease British Journal of Haematology 46(4): 603-612
Kovalenko, V.M.; Shunkova, E.I.; Gol'dberg, G.A.; Karagaeva, L.G.; Shlafer, I.D.; Epifantseva, N.N. 1991: The effect of finoptin on platelet aggregation, blood coagulability and fibrinolysis in patients with ischemic heart disease during physical exercise Kardiologiia 31(9): 42-44
Jespersen, J.; Munkvad, S.; Gram, J.B. 1993: The fibrinolysis and coagulation systems in ischaemic heart disease. Risk markers and their relation to metabolic dysfunction of the arterial intima Danish Medical Bulletin 40(4): 495-502